Disclosures: Stephen Congly: Axcella Health, Inc.: Grant/Research Support, AstraZenica: Grant/Research Support, Merck: Grant/Research Support, Ipsen: Grant/Research Support, Bausch Health: Grant/Research Support, Gilead Sciences Canada: Grant/Research Support, Gilead Sciences Canada: Grant/Research Support, AstraZeneca: Consultant, GSK: Consultant, Conar O'Neil: Gilead Sciences: Speaking and Teaching, Gilead Sciences: Advisor, AbbVie: Speaking and Teaching, ViiV: Advisor, ViiV: Speaking and Teaching, Karen Doucette: Roche: Grant/Research Support, GSK: Grant/Research Support, Altimmune: Grant/Research Support, Mang Ma: Nothing to Disclose, Mayur Brahmania: Nothing to Disclose, Carla Coffin: Gilead Sciences: Grant/Research Support, Janssen Pharmaceuticals: Grant/Research Support, GSK: Speaking and Teaching, Altimmune Pharmacueticals: Fund paid to the University of Calgary, Riche Pharmaceuticals: Grant/Research Support, GSK: Funds paid to the University of Calgary 1710 THE COST OF DILI: EXPLORING HOW DRUG INDUCED LIVER INJURY BURDENS THE U.S
Available from: Peters HPE, Laarakkers CMM, Swinkels DW, Wetzels JFM
Moreover, treating T cells in rheumatoid arthritis with exogenous NAD + or Asp prevents ER expansion and suppresses RA inflammation
However, it's important to note that excessive biotin supplementation has also been associated with acne breakouts in some individuals, highlighting the importance of maintaining balanced nutrient levels rather than pursuing megadoses
